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Caldesmon and troponin are known to control actin-myosin interaction in smooth and striated muscle. We showed that 
polyclonal antibodies to smooth muscle caldesmon,,, cross-react with non-muscle caldesmon,, and with skeletal muscle 
troponin T. The epitope recognized by caldesmon antibodies is located in the CB 2 peptide [residues 7 1-l 511 of troponin 
T. It is supposed that the observed cross-reactivity is due to the common structure of the tropotnyosin-binding site of 
caldesmon and troponin T. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Troponin and caldesmon are involved in the 
thin-filament based regulation of striated and 
smooth muscle contraction [l-3]. In striated 
muscles Ca*+-saturated troponin C relieves the in- 
hibition of actomyosin ATPase induced by tro- 
ponin I and troponin T [ 1,2]. In smooth muscle as 
well as in certain non-muscle tissues the interaction 
of Ca2+ with calmodulin (or with some unknown 
Ca-binding proteins) relieves the inhibition of ac- 
tomyosin ATPase produced by caldesmon [3-51. 
Qualitatively, the mechanisms of troponin-based 
on caldesmon-based regulation are very similar. A 
hypothesis has been put forward suggesting that 
caldesmon can be a precusor of troponin T and/or 
troponin I [3,6]. However, no direct relationship 
between caldesmon and troponin components has 
been established. 
The following proteins and protein complexes were purified 
by previously described methods: chicken gizzard caldesmon 
(150 kDa) [7], bovine liver caldesmon (77 kDa) [8], rabbit 
skeletal and bovine heart troponin complexes and troponin 
components 191, rat and rabbit skeletal and cardiac myofibrils 
[lO,ll]. Chymotrypsinolysis of troponin T was performed ac- 
cording to Tanokura et al. [12] in the absence of urea. The 
largest (about 45 residues) N-terminal tryptic peptide of 
troponin T was isolated as described earlier [ 131. The method of 
Jackson et al. [14] was used for the cleavage of troponin T by 
CNBr. Protein coupling to CNBr-activated Sepharose (Phar- 
macia) was performed according to manufacturer’s instruc- 
tions. 
The present paper is devoted to the investigation 
of immunological relationships between caldesmon 
and troponin components. 
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Aortic smooth muscle cells were isolated from rabbit aorta 
and grown to confluence according to Colucci et al. [15]. An- 
tibodies to chicken gizzard caldesmon were elicited in rabbits 
following the protocol of Ngai and Walsh [16]. The antibodies 
were affinity purified on caldesmon-Sepharose, dialyzed in 
phosphate buffered saline (PBS), aliquoted and stored at 
- 70°C at a concentration of 1.7 mg/ml. Slab polyacrylamide 
gel electrophoresis in the presence of SDS was conducted using 
the method of Laemmli [17]. After electrophoresis the proteins 
were transferred to nitrocellulose paper in semi-dry blotter 
operating at 45 V for 1 h at 4°C. In the case of troponin T pep- 
tides, immediately after the transfer the nitrocellulose was brief- 
ly washed with PBS and soaked in 0.4% glutaraldehyde in PBS 
for 45 min at room temperature. Nonspecific binding sites were 
blocked by immersing the nitrocellulose into PBS containing 
0.05% Tween-20 for 1 h at room temperature. The nitro- 
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cellulose was then incubated with caldesmon antibodies diluted 
to 6 &ml in PBS-Tween-20 for 1 h at room temperature 
followed by overnight incubation at 4°C in 5-fold diluted solu- 
tion of the antibodies. After rinsing of the nitrocellulose in PBS- 
Tween-20 three times for S min, the second antibodies con- 
jugated with peroxidase were applied in the same buffer for 1 h 
at room temperature. Following the incubation the immuno- 
blots were rinsed in PBS-Tween-20 and PBS and developed in a 
solution of chloronaphthol (0.5 mg/ml) in PBS, to which trace 
amounts of Hz02 were added. 
3. RESULTS 
Polyclonal antibodies to chicken gizzard 
caldesmon recognized only caldesmon (150 kDa) in 
the immunoblots of the total protein transfer of 
rabbit aorta smooth muscle (fig. 1). It is well known 
that non-muscle cells contain another isoform of 
caldesmon with a molecular mass of 77 kDa 
[4,5,8]. This isoform is expressed in proliferating 
smooth muscle cells [ 181, and is stained by 
caldesmon antibodies in the total protein transfer 
of subcultured rabbit aorta smooth muscle cells 
(fig. 1). Thus, the antibodies obtained specifically 
recognized two isoforms of caldesmon among all 
proteins of the smooth muscle. 
In our search for immunological relationships 
between caldesmon and the regulatory proteins of 
striated muscle we studied the interaction of 
caldesmon antibodies with proteins of cardiac and 
skeletal myofibrils. Immunoblot analysis of 
myofibrils from mixed rabbit skeletal muscles 
revealed a number of closely separated proteins 
bands of 38 kDa. Similar results were obtained 
with rat skeletal muscle myofibrils, whereas none 
of the proteins was stained in the case of cardiac 
myofibrils (fig.2). The apparent molecular mass of 
the protein recognized by caldesmon antibodies in 
skeletal muscle myofibrils is similar to that of 
troponin T, while the multiplicity of stained bands 
can be due to the presence of troponin T isoforms 
[19,20]. Indeed, in separate experiments we found 
that isolated skeletal troponin T is effectively 
stained by caldesmon antibodies, whereas cardiac 
troponin T is not (fig.3). To obtain a troponin T- 
specific pool of caldesmon antibodies, the latter 
were purified on a column with immobilized 
skeletal troponin T. Thus purified antibodies re- 
tained their ability to recognize two isoforms of 
caldesmon as well as skeletal troponin T. 
In order to identify the epitope recognized by 
caldesmon antibodies in troponin T, we cleaved 
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Fig.1. Control of caldesmon antibodies specificity. A SDS-gel 
electrophoretic pattern of total proteins of rabbit aorta media 
(l), subcultured rabbit aortic smooth muscle cells (3) and cor- 
responding blots (2,4) stained with caldesmon antibodies. The 
arrowheads indicate the positions of caldesmonrSo and 
caldesmonrr; F, filamin; M, myosin heavy chains. 
Fig.2. Staining of myofibrillar proteins with caldesmon an- 
tibodies in immunoblotting. Each lane represents a SDS- 
electropherogram (left) and a corresponding immunoblot (right) 
Lanes: 1, rabbit skeletal muscle myofibrils; 2, rat skeletal mus- 
cle myofibrils; 3, rabbit cardiac myofibrils. The arrowhead in- 
dicates the position of troponin T (38 kDa), A, actin. 
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Fig.3. Cross-reactivity of troponin T and its fragments with 
caldesmon antibodies. Each pair of lanes represents a SDS- 
electropherogram in 15% gel (left) and a corresponding protein 
transfer stained with caldesmon antibodies (right). Lanes: 1, 
rabbit skeletal troponin T and two of its chymotryptic peptides; 
2, CNBr peptides of rabbit skeletal troponin T; 3, bovine car- 
diac troponin T. On the left, an apparent molecular mass scale 
(in kDa). 
this protein by chymotrypsin [ 121. Among the two 
peptides thus obtained, only the larger one (so- 
called Tn Tl fragment, residues - 1-158) was 
stained by caldesmon antibodies (fig.3). Thus, the 
epitope is located in the N-terminal part of 
troponin T. At the same time, the largest N- 
terminal tryptic peptide (about 45 residues) was not 
recognized by caldesmon antibodies in dot-blot ex- 
periments. This indicates that the epitope is located 
somewhere in between residues 45-158 of troponin 
T. To verify this assumption we cleaved troponin T 
by CNBr [14] and separated the peptides by SDS 
gel electrophoresis. In this case caldesmon an- 
tibodies stained only two bands of 22 and 10 kDa. 
These bands correspond to peptides CB 1 (residues 
1-151) and CB 2 (residues 71-151) of rabbit 
skeletal troponin T. The data presented indicate 
that the epitope recognized by caldesmon an- 
tibodies is located in the N-terminal part (residues 
71-15 1) of skeletal troponin T. Since this determi- 
nant was expressed both in glutaraldehyde-treated 
and untreated protein, it seems likely that this 
determinant is not a spatial one which is assembled 
in the course of troponin T refolding on 
nitrocellulose. 
4. DISCUSSION 
In 1984 Lim et al. [21] observed that monoclonal 
antibodies to troponin T cross-react with all muscle 
types. This finding led to a suggestion that 
troponin T and caldesmon are related proteins and 
therefore monoclonal antibodies to troponin T 
recognized caldesmon [3]. Later on, it was found 
that mono- and polyclonal troponin T antibodies 
cross-react with glyceraldehyde phosphate dehy- 
drogenase present in the smooth muscle [22]. 
Moreover, a new protein of 34-36 kDa termed 
calponin was recently isolated from smooth muscle 
[23]. Antibodies to this protein recognized the 
epitope located in the C-terminal part of skeletal 
troponin T. Thus, at present here are at least two 
smooth muscle proteins immunologically related to 
troponin T. At the same time, there is no direct 
evidence of a relationship between caldesmon and 
troponin T. 
Caldesmon and troponin T share many common 
features. Both proteins tightly interact with 
tropomyosin [ 1,2,14,24] and actin [3,4,7,25]. 
Under appropriate conditions both caldesmon and 
troponin T inhibit actomyosin ATPase [3,26]. This 
effect is enhanced by tropomyosin and is partly 
abolished by Ca-binding proteins (troponin C and 
calmodulin) [3,26]. Thus, the hypothesis that 
caldesmon and troponin T are related proteins 
seems to be very plausible. 
The data of the present paper provide the first 
direct evidence that caldesmon and troponin T 
share a common antigenic determinant. The 
epitope is located in the CB 2 peptide (residues 
71-151) of skeletal troponin T. This peptide is in- 
volved in the interaction of troponin T with 
tropomyosin [1,2,22,25,27-J. Since this peptide con- 
tains the antigenic determinant common to 
caldesmon and troponin T, one can suppose that 
the corresponding region of caldesmon is also in- 
volved in the interaction with tropomyosin. If this 
assumption is correct the question arises as to why 
this epitope is absent in cardiac troponin T which is 
also able to interact with tropomyosin. A com- 
parison of the primary structure of cardiac and 
skeletal muscle troponin T in the vicinity of 
tropomyosin-binding site reveals a strong homo- 
logy [27]. Nevertheless, the sequence between 
residues 133 and 143 of rabbit skeletal muscle 
troponin T differs from the corresponding se- 
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quence of bovine cardiac troponin T (residues 
160-l 70) by eight conservative substitutions. Since 
this stretch of amino acids contains the largest 
number of replacements, one may suppose that 
caldesmon antibodies recognized the epitope 
restricted by residues 133-143 of skeletal muscle 
troponin T. Our future investigations will be aimed 
at the verification of this hypothesis and at the 
evaluation of the physiological significance of the 
common determinant found in caldesmon and 
troponin T. 
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